Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

被引:346
作者
Dandri, M
Burda, MR
Török, E
Pollok, JM
Iwanska, A
Sommer, G
Rogiers, X
Rogler, CE
Gupta, S
Will, H
Greten, H
Petersen, J
机构
[1] Univ Hamburg, Univ Hosp Eppendorf, Heinrich Pette Inst Expt Virol & Immunol, Hamburg, Germany
[2] Univ Hamburg, Univ Hosp Eppendorf, Dept Hepatobiliary Surg & Transplantat, Hamburg, Germany
[3] Univ Hamburg, Univ Hosp Eppendorf, Dept Med, Hamburg, Germany
[4] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10467 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/jhep.2001.23314
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mice containing livers repopulated with human hepatocytes would provide excellent in vivo models for studies on human liver diseases and hepatotropic viruses, for which no permissive cell lines exist. Here, we report partial repopulation of the liver of immunodeficient urokinase-type plasminogen activator (uPA)/recombinant activation gene-2 (RAG-2) mice with normal human hepatocytes isolated from the adult liver. In the transplanted mice, the production of human albumin was demonstrated, indicating that human hepatocytes remained functional in the mouse liver for at least 2 months after transplantation. Inoculation of transplanted mice with human hepatitis B virus (HBV) led to the establishment of productive HBV infection. According to human-specific genomic DNA analysis and immunostaining of cryostat liver sections, human hepatocytes were estimated to constitute up to 15% of the uPA/RAG-2 mouse liver. This is proof that normal human hepatocytes can integrate into the mouse hepatic parenchyma, undergo multiple cell divisions, and remain permissive for a human hepatotropic virus in a xenogenic liver. This system will provide new opportunities for studies on etiology and therapy of viral and nonviral human liver diseases, as well as on hepatocyte biology and hepatocellular transplantation.
引用
收藏
页码:981 / 988
页数:8
相关论文
共 44 条
  • [31] Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes
    Mignon, A
    Guidotti, JE
    Mitchell, C
    Fabre, M
    Wernet, A
    De La Coste, A
    Soubrane, O
    Gilgenkrantz, H
    Kahn, A
    [J]. NATURE MEDICINE, 1998, 4 (10) : 1185 - 1188
  • [32] Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus
    Ogata, N
    Cote, PJ
    Zanetti, AR
    Miller, RH
    Shapiro, M
    Gerin, J
    Purcell, RH
    [J]. HEPATOLOGY, 1999, 30 (03) : 779 - 786
  • [33] Ohashi K, 2000, NAT MED, V6, P327
  • [34] Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
    Overturf, K
    AlDhalimy, M
    Tanguay, R
    Brantly, M
    Ou, CN
    Finegold, M
    Grompe, M
    [J]. NATURE GENETICS, 1996, 12 (03) : 266 - 273
  • [35] Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma
    Petersen, J
    Dandri, M
    Gupta, S
    Rogler, CE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) : 310 - 315
  • [36] REPLACEMENT OF DISEASED MOUSE-LIVER BY HEPATIC CELL TRANSPLANTATION
    RHIM, JA
    SANDGREN, EP
    DEGEN, JL
    PALMITER, RD
    BRINSTER, RL
    [J]. SCIENCE, 1994, 263 (5150) : 1149 - 1152
  • [37] COMPLETE RECONSTITUTION OF MOUSE-LIVER WITH XENOGENEIC HEPATOCYTES
    RHIM, JA
    SANDGREN, EP
    PALMITER, RD
    BRINSTER, RL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 4942 - 4946
  • [38] ROGLER CE, 1991, CURR TOP MICROBIOL, V168, P103
  • [39] COMPLETE HEPATIC REGENERATION AFTER SOMATIC DELETION OF AN ALBUMIN-PLASMINOGEN ACTIVATOR TRANSGENE
    SANDGREN, EP
    PALMITER, RD
    HECKEL, JL
    DAUGHERTY, CC
    BRINSTER, RL
    DEGEN, JL
    [J]. CELL, 1991, 66 (02) : 245 - 256
  • [40] SCOTTO J, 1983, HEPATOLOGY, V3, P279